Your browser doesn't support javascript.
loading
Real-World Cabazitaxel Use and Outcomes in Metastatic Castrate-Resistant Prostate Cancer: The Impact of Response to First ARPI.
Watson, Alexander S; Gagnon, Richard; Batuyong, Eugene; Alimohamed, Nimira; Lee-Ying, Richard.
Affiliation
  • Watson AS; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada.
  • Gagnon R; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada.
  • Batuyong E; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada.
  • Alimohamed N; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada.
  • Lee-Ying R; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada. Electronic address: richard.lee-ying@albertahealthservices.ca.
Clin Genitourin Cancer ; 20(5): 496.e1-496.e9, 2022 10.
Article in En | MEDLINE | ID: mdl-35599196
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Limits: Humans / Male Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2022 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Limits: Humans / Male Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2022 Type: Article Affiliation country: Canada